BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

16913

542919

ARTEMISMED

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ARTEMIS MED SERVICE LTD performance

Today’s low

Today’s high

₹ 251.10 ₹ 255.80
₹ 251.80

52 week low

52 week high

₹ 183.26 ₹ 350.00
₹ 251.80

Open Price

₹ 252.50

Prev. Close

₹ 252.50

Volume (Shares)

1172.00

Total traded value

₹ 2.95

Upper Circuit

₹ 302.45

Lower Circuit

₹ 201.65

info

ARTEMIS MED SERVICE LTD Share Price Update

As of the latest trading session, ARTEMIS MED SERVICE LTD share price is currently at ₹ 254.95, which is up by ₹ 2.44 from its previous closing. Today, the stock has fluctuated between ₹ 251.10 and ₹ 255.80. Over the past year, ARTEMIS MED SERVICE LTD has achieved a return of 34.26 %. In the last month alone, the return has been -4.80 %. Read More...

Investment Returns

Over 1 Month -4.80% Over 3 Months -10.19% Over 6 Months -21.15% Over 1 Year 34.26%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ARTEMIS MED SERVICE LTD fundamentals


  • Market cap (Cr)

    3,508.00

  • P/E Ratio (TTM)

    41.97

  • Beta

    1.12

  • Book Value / share

    55.67

  • Return on equity

    14.43%

  • EPS (TTM)

    6.01

  • Dividend yield

    0.18%

  • Net profit/quarter (Cr)

    23.20

info icon alternate text
  • Market cap (Cr)

    3,504.60

  • P/E Ratio (TTM)

    41.97

  • Beta

    1.10

  • Book Value / share

    55.67

  • Return on equity

    14.43%

  • EPS (TTM)

    6.01

  • Dividend yield

    0.18%

  • Net profit/quarter (Cr)

    23.20

info icon alternate text

ARTEMIS MED SERVICE LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 234.80
Operating Expense 218.04
Net Profit 23.20
Net Profit Margin (%) 9.88
Earnings Per Share (EPS) 1.48
EBITDA 47.78
Effective Tax Rate (%) 19.96
Particulars DEC 2024 (Values in Cr)
Revenue 226.89
Operating Expense 208.65
Net Profit 20.78
Net Profit Margin (%) 9.15
Earnings Per Share (EPS) 1.33
EBITDA 45.62
Effective Tax Rate (%) 23.15
Particulars SEP 2024 (Values in Cr)
Revenue 234.67
Operating Expense 211.09
Net Profit 22.56
Net Profit Margin (%) 9.61
Earnings Per Share (EPS) 1.44
EBITDA 49.28
Effective Tax Rate (%) 27.41
Particulars JUN 2024 (Values in Cr)
Revenue 216.89
Operating Expense 199.14
Net Profit 16.92
Net Profit Margin (%) 7.80
Earnings Per Share (EPS) 1.16
EBITDA 40.06
Effective Tax Rate (%) 23.57
Particulars MAR 2024 (Values in Cr)
Revenue 216.87
Operating Expense 199.30
Net Profit 13.92
Net Profit Margin (%) 6.41
Earnings Per Share (EPS) 1.02
EBITDA 37.98
Effective Tax Rate (%) 28.39
Particulars MAR 2025 (Values in Cr)
Revenue 913.26
Operating Expense 836.92
Net Profit 83.46
Net Profit Margin (%) 9.13
Earnings Per Share (EPS) 5.42
EBITDA 182.75
Effective Tax Rate (%) 23.61
Particulars MAR 2024 (Values in Cr)
Revenue 845.23
Operating Expense 784.47
Net Profit 49.15
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 3.62
EBITDA 135.66
Effective Tax Rate (%) 27.76
Particulars MAR 2023 (Values in Cr)
Revenue 714.33
Operating Expense 668.60
Net Profit 39.69
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 2.98
EBITDA 100.92
Effective Tax Rate (%) 24.93
Particulars MAR 2022 (Values in Cr)
Revenue 544.78
Operating Expense 509.86
Net Profit 32.58
Net Profit Margin (%) 5.98
Earnings Per Share (EPS) 2.46
EBITDA 71.06
Effective Tax Rate (%) 16.05
Particulars MAR 2021 (Values in Cr)
Revenue 402.06
Operating Expense 399.94
Net Profit 7.09
Net Profit Margin (%) 1.76
Earnings Per Share (EPS) 0.54
EBITDA 41.83
Effective Tax Rate (%) 20.42
Particulars MAR 2025 (Values in Cr)
Book Value / Share 55.90
ROE % 14.30
ROCE % 15.66
Total Debt to Total Equity 0.53
EBITDA Margin 19.72
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.00
ROE % 13.72
ROCE % 14.87
Total Debt to Total Equity 0.85
EBITDA Margin 15.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.03
ROE % 12.10
ROCE % 12.41
Total Debt to Total Equity 0.78
EBITDA Margin 13.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.10
ROE % 11.50
ROCE % 10.81
Total Debt to Total Equity 0.64
EBITDA Margin 12.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 191.73
ROE % 2.33
ROCE % 4.51
Total Debt to Total Equity 0.52
EBITDA Margin 9.54
Particulars MAR 2025 (Values in Cr)
Book Value / Share 56.20
ROE % 14.43
ROCE % 15.83
Total Debt to Total Equity 0.51
EBITDA Margin 20.01
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.24
ROE % 13.60
ROCE % 14.85
Total Debt to Total Equity 0.79
EBITDA Margin 16.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.28
ROE % 12.53
ROCE % 12.88
Total Debt to Total Equity 0.72
EBITDA Margin 14.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.26
ROE % 11.85
ROCE % 11.20
Total Debt to Total Equity 0.60
EBITDA Margin 13.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 192.81
ROE % 2.52
ROCE % 4.77
Total Debt to Total Equity 0.49
EBITDA Margin 9.65
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 395.53
Total Assets 1357.40
Total Liabilities 1357.40
Total Equity 843.55
Share Outstanding 137602250
Price to Book Ratio 4.89
Return on Assets (%) 6.08
Return on Capital (%) 7.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.34
Total Assets 971.51
Total Liabilities 971.51
Total Equity 454.68
Share Outstanding 135860500
Price to Book Ratio 6.01
Return on Assets (%) 5.05
Return on Capital (%) 6.94
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 50.94
Total Assets 904.95
Total Liabilities 904.95
Total Equity 407.68
Share Outstanding 134118750
Price to Book Ratio 2.69
Return on Assets (%) 4.26
Return on Capital (%) 5.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 27.69
Total Assets 709.66
Total Liabilities 709.66
Total Equity 361.26
Share Outstanding 132377000
Price to Book Ratio 2.06
Return on Assets (%) 4.48
Return on Capital (%) 5.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 31.11
Total Assets 600.08
Total Liabilities 600.08
Total Equity 321.74
Share Outstanding 13237700
Price to Book Ratio 1.15
Return on Assets (%) 1.08
Return on Capital (%) 1.44
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 393.26
Total Assets 1343.10
Total Liabilities 1343.10
Total Equity 841.79
Share Outstanding 137602250
Price to Book Ratio 4.89
Return on Assets (%) 6.21
Return on Capital (%) 7.74
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 57.93
Total Assets 948.03
Total Liabilities 948.03
Total Equity 451.63
Share Outstanding 135860500
Price to Book Ratio 6.01
Return on Assets (%) 5.18
Return on Capital (%) 7.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 48.32
Total Assets 881.83
Total Liabilities 881.83
Total Equity 406.42
Share Outstanding 134118750
Price to Book Ratio 2.69
Return on Assets (%) 4.50
Return on Capital (%) 6.3
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 27.11
Total Assets 697.40
Total Liabilities 697.40
Total Equity 361.61
Share Outstanding 132377000
Price to Book Ratio 2.06
Return on Assets (%) 4.67
Return on Capital (%) 6.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 28.84
Total Assets 588.95
Total Liabilities 588.95
Total Equity 321.62
Share Outstanding 13237700
Price to Book Ratio 1.15
Return on Assets (%) 1.20
Return on Capital (%) 1.61
Particulars MAR 2025 (Values in Cr)
Net Income 107.66
Cash from Operations 159.46
Cash from Investing -385.38
Cash from Financing 266.74
Net change in Cash 26.97
Free Cash Flow 252.61
Particulars MAR 2024 (Values in Cr)
Net Income 68.45
Cash from Operations 124.45
Cash from Investing -88.13
Cash from Financing -28.97
Net change in Cash -8.25
Free Cash Flow 197.00
Particulars MAR 2023 (Values in Cr)
Net Income 50.60
Cash from Operations 130.03
Cash from Investing -158.21
Cash from Financing 38.22
Net change in Cash 7.16
Free Cash Flow 276.50
Particulars MAR 2022 (Values in Cr)
Net Income 37.18
Cash from Operations 42.82
Cash from Investing -107.22
Cash from Financing 44.22
Net change in Cash -3.46
Free Cash Flow 151.73
Particulars MAR 2021 (Values in Cr)
Net Income 7.53
Cash from Operations 29.39
Cash from Investing -37.42
Cash from Financing 17.71
Net change in Cash 7.55
Free Cash Flow 63.89
Particulars MAR 2025 (Values in Cr)
Net Income 109.25
Cash from Operations 153.09
Cash from Investing -388.28
Cash from Financing 276.95
Net change in Cash 27.75
Free Cash Flow 246.08
Particulars MAR 2024 (Values in Cr)
Net Income 68.04
Cash from Operations 121.94
Cash from Investing -89.90
Cash from Financing -26.09
Net change in Cash -8.41
Free Cash Flow 193.74
Particulars MAR 2023 (Values in Cr)
Net Income 52.86
Cash from Operations 131.80
Cash from Investing -152.53
Cash from Financing 29.73
Net change in Cash 6.55
Free Cash Flow 267.67
Particulars MAR 2022 (Values in Cr)
Net Income 38.80
Cash from Operations 76.99
Cash from Investing -106.09
Cash from Financing 43.65
Net change in Cash -1.77
Free Cash Flow 183.53
Particulars MAR 2021 (Values in Cr)
Net Income 8.90
Cash from Operations 29.41
Cash from Investing -34.07
Cash from Financing 12.72
Net change in Cash 5.69
Free Cash Flow 57.68
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7358.90 73.18 12.89 105809.69 6002.15 / 7634.45
FORTIS MALAR HOSPITALS LIMITED 71.47 340.33 4.43 133.95 51.01 / 98.70
SHREE PACETRONIX LTD. 91.28 43.88 2.38 32.86 61.11 / 221.50
TRANSGENE BIOTEK LTD. 4.99 0.00 3.76 37.81 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7358.90 81.62 12.11 105809.69 6002.15 / 7634.45
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.02 0.00 -13.05 24.67 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6461.00 33.83 6.50 7068.33 4067.50 / 6500.00

ARTEMIS MED SERVICE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
252.50 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 252.10
  • 26 Days 254.80
  • 10 Days 252.40
  • 50 Days 257.70
  • 12 Days 252.70
  • 100 Days 262.80
  • 20 Days 253.90
  • 200 Days 261.50
253.17 PIVOT

First Support

249.33

First Resistance

256.33

Second Support

246.17

Second Resistance

260.17

Third Support

242.33

Third Resistance

263.33

RSI

47.21

ADX

39.26

MACD

-2.09

Williams % R

-68.36

Commodity Channel Index (CCI)

9.27

Date

2025-07-10

Week

39545.00

Same Day

32970.00

Month

37764.00

1 Year

1.12

3 Year

0.78

Over 1 Month

-4.80%

down

Over 1 Year

34.26%

down

Over 3 Months

-10.19%

down

Over 3 Years

78.22%

down

Over 6 Months

-21.15%

down

Over 5 Years

69.64%

down

ARTEMIS MED SERVICE LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
27.47%
Promoter Holdings
67.17%
FII
0.3%
DII
5.04%
Promoter Shares(Pledge Percentage)
44.53%
Name Shares Category
Constructive Finance Private Limited 9.242579E7 (67.17%) Shareholding of Promoter and Promoter Group
Governor Of Kerala 6749600.0 (4.91%) Public Shareholding
Devlina Chakravarty 3474327.0 (2.52%) Public Shareholding
Kerala State Industrial Development Corporation 3000000.0 (2.18%) Public Shareholding
Artemis Medicare Services Limited-unclaimed Suspense Account 2350520.0 (1.71%) Public Shareholding
International Finance Corporation 0.0 (0.0%) Public Shareholding
Onkar Kanwar 5000.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ARTEMIS MED SERVICE LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
11 Jul 2025 0.45 Final 11 Jul 2025 Equity shares
05 Jul 2024 0.45 Final 05 Jul 2024 Equity shares
14 Jul 2023 0.45 Final 14 Jul 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
23 Sep 2021 10.0 1.0 24 Sep 2021
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
11 Jul 2025 0.45 Final 11 Jul 2025 Equity shares
05 Jul 2024 0.45 Final 05 Jul 2024 Equity shares
14 Jul 2023 0.45 Final 14 Jul 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
23 Sep 2021 10.0 1.0 24 Sep 2021

ARTEMIS MED SERVICE LTD Share Price

Artemis Medicare Services Limited was incorporated on May 18, 2004. It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007. The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary Company of Constructive Finance Private Limited. At present, the Company is engaged in managing and operating of multi specialty hospitals. Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multi-speciality hospital located in Gurugram, India.

Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group. Designed as one of the most advanced in India, the Company provides a depth of expertise in the spectrum of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services.

Artemis Hospital is the first to introduce Masimo technology based on Clinical Surveillance System and equipped with North India's first M6 Cyber knife having performed over 1000 procedures. The hospital has an impeccable track record and high success rates even in surgeries of high complexity such as transplants, cardiac care and oncology.

In addition to the focus on clinical excellence, the Hospital ensures that medical professionals and other staff are periodically trained on the newest techniques and procedures in the medical field on a periodic and continuous basis. The Hospital has put modern technology in the hands of renowned doctors from India and abroad as well to set new standards in healthcare. The medical practices and procedures followed in the hospital are research oriented and bench-marked against the best in the world. Top-notch services, in a warm, open patient centric environment, clubbed with affordability, has made the Unit one of the most revered hospitals in the country.

Artemis Hospital received accreditation from the Joint Commission International, USA (JCI) for meeting international healthcare quality standards for patient care and management. The Hospital in Gurugram was accredited with JCI and NABH (National Accreditation Board for Hospitals) within 3 years of start up. The hospital also received Green OT certification from Bureau Veritas.

In 2019-20, the amalgamation of Artemis Health Sciences Limited, Athena Eduspark Limited and Artemis Global Life Sciences Limited with the Company through the Scheme of Amalgamation was made effective from 01 April, 2018. In terms of the said Scheme. the Company allotted on October 26, 2019 an aggregate of 1,32,37,700 Equity Shares of Rs 10/- each to shareholders of Artemis Global Life Sciences Limited pursuant to Composite Scheme of Amalgamation.

The Company commenced operations of new Tower II in Gurugram in 2022. Resulting the expansion of the Hospital Building, the bed capacity of the Hospital increased from 394 beds to 541 beds in 2022. The Company opened two new units of Daffodils by Artemis', one each in Jaipur and South Delhi in addition to the one already operating in Gurugram in 2023. In addition to this, it introduced the , multi-speciality hospital under the brand of Artemis Lite' catering to secondary/ tertiary care market and opened the first centre in South Delhi in 2023.

In 2024, the Company fully operationalised the remaining beds in the second tower and focused on improving operational and financial metrics. It opened a new unit under the Artemis Lite' brand in New Gurugram area in June, 2023. Further, the Company inaugurated the first of the two hospitals in Mauritius, a ~80-bed facility under the brand of Artemis Curepipe Hospital' as part of the Operations and Management agreement. It ramped up operations in the said Facility and achieved a good start in its commencement year.

Parent organization Indian Private
NSE symbol ARTEMISMED
Founded 2004
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Artemis Medicare Services Ltd?

Answer Field

Artemis Medicare Services Ltd share price is for NSE ₹ 254.95 & for BSE ₹ 254.45 as on Jul 11 2025 09:56 AM.

What is the Market Cap of Artemis Medicare Services Ltd Share?

Answer Field

The market cap of Artemis Medicare Services Ltd for NSE ₹ 3,508.16 & for BSE ₹ 3,501.29 as on Jul 11 2025 09:56 AM.

What is the 52 Week High and Low of Artemis Medicare Services Ltd?

Answer Field

The 52 Week High and Low of Artemis Medicare Services Ltd for NSE is ₹ 350.00 and ₹ 183.26 and for BSE is ₹ 348.30 and ₹ 183.00.

What is 1 year return for Artemis Medicare Services Ltd?

Answer Field

The 1 year returns on the stock has been 34.26%.

What is the P/E Ratio of Artemis Medicare Services Ltd Share?

Answer Field

As on Jul 11 2025 09:56 AM the price-to-earnings (PE) ratio for Artemis Medicare Services Ltd share is 41.97.

What is the PB ratio of Artemis Medicare Services Ltd Share?

Answer Field

As on Jul 11 2025 09:56 AM, the price-to-book (PB) ratio for Artemis Medicare Services Ltd share is 55.67.

How to Buy Artemis Medicare Services Ltd Share?

Answer Field

You can trade in Artemis Medicare Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Artemis Medicare Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Artemis Medicare Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Artemis Medicare Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|